Risk factors for unsuccessful tuberculosis treatment outcomes in children.
PLoS One
http://www.ncbi.nlm.nih.gov/pubmed/31553758
Evaluation of GenoType MTBDRplus for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan.
PLoS One
http://www.ncbi.nlm.nih.gov/pubmed/31425565
Reply to te Brake et al.: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
Am J Respir Crit Care Med
http://www.ncbi.nlm.nih.gov/pubmed/30645140
Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant Tuberculosis.
Antimicrob Agents Chemother
http://www.ncbi.nlm.nih.gov/pubmed/30803975
Use of predicted vital status to improve survival analysis of multidrug-resistant tuberculosis cohorts.
BMC Med Res Methodol
http://www.ncbi.nlm.nih.gov/pubmed/30537944
Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial.
Am J Respir Crit Care Med
http://www.ncbi.nlm.nih.gov/pubmed/29954183